HARMONY 3: 104 week efficacy of albiglutide compared to sitagliptin and glimepiride in patients with type 2 diabetes mellitus on metformin

被引：0
|
作者：
Johnson, S. [1 ]
Ahren, B. [2 ]
Stewart, M.
Cirkel, D. [3 ]
Yang, F.
Perry, C.
机构：
[1] GlaxoSmithKline, Res Triangle Pk, NC USA
[2] Lund Univ, S-22100 Lund, Sweden
[3] GlaxoSmithKline, Stevenage, Herts, England
来源：
DIABETOLOGIA | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5
引用
收藏
页码：S8 / S9
页数：2
相关论文
共 50 条
  • [41] Efficacy of Sitagliptin Versus Glimepiride 1-3 mg for Treatment of Type-2 Diabetes Patients
    Joshi, Bhaskar
    Yadav, Praveen
    Bhavani, Annabathini Geetha
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2020, 10 (04) : 590 - 593
  • [42] Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study
    Williams-Herman, Debora
    Johnson, Jeremy
    Teng, Rujun
    Luo, Edmund
    Davies, Michael J.
    Kaufman, Keith D.
    Goldstein, Barry J.
    Amatruda, John M.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (03) : 569 - 583
  • [43] Harmony 5 Year 3 Results: Albiglutide vs. Placebo and vs. Pioglitazone in Triple Therapy (Background Metformin and Glimepiride) in People with Type 2 Diabetes
    Home, Philip
    Stewart, Murray
    Mallory, Jason
    Miller, Diane
    Perry, Caroline
    Shamanna, Paramesh
    Carr, Molly C.
    DIABETES, 2014, 63 : A247 - A247
  • [44] Albiglutide for the treatment of type 2 diabetes mellitus: An integrated safety analysis of the HARMONY phase 3 trials
    Ahren, Bo
    Carr, Molly C.
    Murphy, Karen
    Perkins, Christopher
    Rendell, Marc
    Mallory, Jason
    Wilson, Timothy
    Johnson, Susan
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 126 : 230 - 239
  • [45] Empaglilozin compared with glimepiride as add-on to metformin for 2 years in patients with type 2 diabetes
    Ridderstrale, M.
    Andersen, K. R.
    Zeller, C.
    Kim, G.
    Woerle, H. J.
    Broedl, U. C.
    DIABETOLOGIA, 2014, 57 : S7 - S8
  • [46] Safety and Efficacy of Sitagliptin-Metformin in Fixed Combination for the Treatment of Type 2 Diabetes Mellitus
    Ballav, Chitrabhanu
    Gough, Stephen C. L.
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2013, 6 : 25 - 37
  • [47] Safety and efficacy of ertugliflozin compared to glimepiride in patients with type 2 diabetes inadequately controlled on metformin: the VERTIS SU trial
    Hollander, P.
    Liu, J.
    Hill, J.
    Johnson, J.
    Jiang, Z.
    Golm, G.
    Huyck, S.
    Terra, S.
    Mancuso, J. P.
    Engel, S.
    Lauring, B.
    DIABETOLOGIA, 2017, 60 : S19 - S20
  • [48] Efficacy and safety of a fixed dose combination of glimepiride and sustained release metformin in Indian patients with type 2 diabetes mellitus
    Desai, AA
    Singh, KP
    Rajadhyaksha, GC
    Anandmoses, CR
    Ballary, CC
    Gawde, AS
    DIABETES, 2004, 53 : A474 - A474
  • [49] Sitagliptin/Metformin Fixed-Dose CombinationIn Patients with Type 2 Diabetes Mellitus
    Claudine M. Chwieduk
    Drugs, 2011, 71 : 349 - 361
  • [50] Efficacy and safety of gemigliptin compared with sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone
    Rhee, E. J.
    Min, K. W.
    Jang, H. C.
    Chung, C. H.
    Nam-Goong, I. S.
    Bae, H. Y.
    Lee, M. K.
    Baik, S. H.
    Shivane, V. K.
    Sosale, A. R.
    Dharmalingam, M.
    Gandhi, P.
    Gupta, S. K.
    Kim, J. A.
    Kim, S. W.
    DIABETOLOGIA, 2012, 55 : S352 - S352
12345